SEP 18, 2026 · JOURNAL ARTICLE
Targeting KRAS-Mutant Lung Cancers
Journal of the National Comprehensive Cancer Network
KRAS mutations are the most common oncogenic driver alterations in non–small cell lung cancer (NSCLC) and define biologically heterogeneous diseases shaped by mutation subtype, co-